Literature DB >> 1944409

Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.

M B Bromberg1.   

Abstract

Three sets of electrodiagnostic criteria for establishing primary demyelination in chronic polyneuropathy are evaluated. Sensitivity is assessed in 70 patients with clinically established chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The criteria use different abnormal values, one adjusts for the effects of axonal loss, while another relies only on conduction velocity. However, even when consideration is given to sufficient number of nerves tested, there is no significant difference (P = 0.37) in diagnostic sensitivity among them, with 48% to 64% of CIDP patients fulfilling criteria for primary demyelination. Specificity is assessed by applying the criteria to 47 patients with motor neuron disease and 63 patients with diabetic polyneuropathy. No patients meet any of the criteria. Further analysis shows that as sensitivity increases specificity decreases, because of overlapping distributions of nerve conduction abnormalities in these neuropathic disorders. A sensitivity of approximately 66% is a practical limit for electrodiagnostic criteria in CIDP.

Entities:  

Mesh:

Year:  1991        PMID: 1944409     DOI: 10.1002/mus.880141007

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

Review 1.  Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.

Authors:  David S Saperstein; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

2.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

3.  Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Y-C Chan; D C Allen; D Fialho; K R Mills; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

4.  Incidence and prevalence of CIDP and the association of diabetes mellitus.

Authors:  R S Laughlin; P J Dyck; L J Melton; C Leibson; J Ransom; P J B Dyck
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

5.  Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline.

Authors:  N R Rosenberg; P Portegies; M de Visser; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

6.  Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.

Authors:  T Maisonobe; B Chassande; M Vérin; M Jouni; J M Léger; P Bouche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

7.  Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  Jonathan S. Katz; David S. Saperstein
Journal:  Curr Treat Options Neurol       Date:  2003-09       Impact factor: 3.598

8.  Chronic idiopathic axonal polyneuropathy revisited.

Authors:  Nathalie R Rosenberg; Marinus Vermeulen
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

9.  Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  J Meulstee; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

10.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.